The global AI-based clinical trial solutions for patient matching market was valued at USD 253.13 million in 2022 and is projected to reach USD 2,876.37 million by 2032, expanding at a CAGR of 29.2% from 2023 to 2032. These findings come from the latest Polaris Market Research study, AI-based Clinical Trial Solutions for Patient Matching Market , which evaluates the factors shaping demand, the segments and regions expected to contribute most to growth, and the strategies adopted by leading companies.

The study combines primary and secondary research with quantitative forecasting to give stakeholders a clear, data-backed view of the market.

AI-Based Clinical Trial Solutions for Patient Matching Market Report Snapshot

• Base year: 2022
• Forecast period: 2023–2032
• Market size: USD 253.13 million (2022) → USD 2,876.37 million (2032)
• CAGR: 2% (2023–2032)
• Largest segments: Oncology (therapeutic application); Pharmaceutical companies (end-use)
• Leading region: North America
• Fastest-growing region: Asia Pacific
• Segments covered: Therapeutic application, end-use, region
• Regions covered: North America, Europe, Asia Pacific, Latin America, Middle East & Africa

What Does the AI-Based Clinical Trial Solutions for Patient Matching Market Include?

AI-based clinical trial solutions for patient matching use artificial intelligence to identify and enroll patients who meet trial criteria. They analyze electronic medical records, medical imaging and omics data, helping pharmaceutical companies and academic institutions improve recruitment, engagement and real-time monitoring.

Browse Insights:

https://www.polarismarketresearch.com/industry-analysis/ai-based-clinical-trial-solutions-for-patient-matching-market

Why Is the AI-Based Clinical Trial Solutions for Patient Matching Market Growing?

Demand- and supply-side factors shape adoption and revenue.

Advances in AI and Machine Learning

Sophisticated algorithms now analyze large datasets, including demographics, medical history, genetic profiles and lifestyle information, to match patients with trial criteria accurately and efficiently.

Personalized Medicine and Efficient Recruitment

Personalized therapies require patients with specific biomarkers, while traditional recruitment is slow and costly. AI-based matching uses predictive modeling to speed enrollment and improve retention.

Pharma–AI Partnerships in Oncology

Pharmaceutical companies are partnering with AI developers in cancer research. Deep Lens's collaboration with Hematology-Oncology Associates of Central New York and Survivor Net's AI-powered trial finder illustrate this trend.

What Could Hold the Market Back?

Data privacy concerns are the key restraint, since large volumes of sensitive trial data stored in the cloud face cybersecurity risks. However, Asia Pacific's large patient population, skilled yet affordable labor and sevenfold rise in clinical trial registration give solution providers an opportunity to expand trial recruitment and grow their presence.

Which Segments Lead the AI-Based Clinical Trial Solutions for Patient Matching Market?

The report segments the AI-based clinical trial solutions for patient matching market by therapeutic application, end-use and region, assessing each for revenue contribution and growth.

• Therapeutic application: Oncology — rising global cancer incidence and more clinical trials led in 2022.
• End-use: Pharmaceutical companies — growing use of AI in drug target discovery and biomarker identification.

Which Region Holds the Largest Share?

North America accounted for the largest share of the global AI-based clinical trial solutions for patient matching market in 2022, supported by prominent companies, AI startups and abundant registered clinical studies. Asia Pacific is anticipated to register the highest CAGR through 2032, driven by growing AI adoption and pro-AI government initiatives. The report also assesses Europe, Latin America, and the Middle East & Africa.

Who Are the Leading Companies in the AI-Based Clinical Trial Solutions for Patient Matching Market?

The market features a mix of established companies and emerging players. The report profiles key participants and evaluates their product portfolios, financial performance, and strategic initiatives, including partnerships, investments, and regional expansion.

Key companies profiled in the report include:

Unlearn.AI, Inc.; Antidote Technologies, Inc.; Deep6.ai; Mendel.ai; Aris Global; Deep Lens; AmerisourceBergen Corporation; Koneksa; Microsoft Corporation; and GNS Healthcare.

Frequently Asked Questions

How big is the AI-based clinical trial solutions for patient matching market?

The market was valued at USD 253.13 million in 2022. It is projected to reach USD 2,876.37 million by 2032.

What is the growth rate of the AI-based clinical trial solutions for patient matching market?

The market is expected to grow at a CAGR of 29.2% from 2023 to 2032, driven by AI advances and personalized medicine demand.

Which segment dominates the AI-based clinical trial solutions for patient matching market?

Oncology leads by therapeutic application and pharmaceutical companies lead AI-based Clinical Trial Solutions For Patient Matching Market by end-use, both holding the largest revenue share in 2022.

Which region is growing the fastest in the AI-based clinical trial solutions for patient matching market?

Asia Pacific is projected to grow at the highest CAGR, while North America held the largest share in 2022.

Who are the key players in the AI-based clinical trial solutions for patient matching market?

Key players include Unlearn.AI, Antidote Technologies, Deep6.ai, Mendel.ai, Aris Global, Deep Lens, and Microsoft Corporation.

About Polaris Market Research & Consulting, Inc.

Polaris Market Research & Consulting, Inc. is a market research and consulting company offering syndicated research reports, customized research, and consulting services across 20+ industry verticals. Its library of 5,000+ reports helps businesses, investors, and decision-makers understand market size, competitive dynamics, and emerging opportunities in their industries.

More Trending Latest Reports By Polaris Market Research:

leading-top-10-companies-in-drone-batteries-market-to-know-in-2025

methanol-market

global-gypsum-board-market

global-soda-ash-market

distributed-antenna-system-das-market

esg-advisory-market

athletic-footwear-market

adhesives-sealants-market

insurtech-market